Osteopore (ASX:OSX) Receivables Turnover: 1.16 (As of Dec. 2025)


What is Osteopore Receivables Turnover?

Osteopore ASX:OSX -20.00% Receivables Turnover is 1.16 as of Dec. 2025. The stock has 7 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Osteopore ranks worse than 87.19% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Osteopore's Revenue for the six months ended in Dec. 2025 was A$1.50 Mil. Osteopore's average Accounts Receivable for the six months ended in Dec. 2025 was A$1.30 Mil. Hence, Osteopore's Receivables Turnover for the six months ended in Dec. 2025 was 1.16.


Osteopore  (ASX:OSX) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Osteopore Receivables Turnover Related Terms


Osteopore Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Osteopore's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Osteopore Receivables Turnover Chart

Osteopore Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Receivables Turnover
Get a 7-Day Free Trial 2.99 2.50 2.95 4.26 3.07

Osteopore Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.23 2.12 1.81 1.45 1.16

ASX:OSX vs ISRG, BDX, MDLN: Receivables Turnover Comparison

For the Medical Instruments & Supplies subindustry, Osteopore's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Osteopore Receivables Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Osteopore's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Osteopore's Receivables Turnover falls into.



Osteopore Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Osteopore's Receivables Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Receivables Turnover (A: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2025 ) / ((Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count )
=3.057 / ((0.78 + 1.214) / 2 )
=3.057 / 0.997
=3.07

Osteopore's Receivables Turnover for the quarter that ended in Dec. 2025 is calculated as

Receivables Turnover (Q: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Dec. 2025 ) / ((Accounts Receivable (Q: Jun. 2025 ) + Accounts Receivable (Q: Dec. 2025 )) / count )
=1.498 / ((1.376 + 1.214) / 2 )
=1.498 / 1.295
=1.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 1.16 mean?
Osteopore (ASX:OSX) has a Receivables Turnover of 1.16 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Osteopore and its competitors. According to the industry distribution chart, Osteopore ranks #708 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 87.2%.
Is Osteopore's Receivables Turnover too high?
Osteopore's current Receivables Turnover is 1.16. The Medical Devices & Instruments industry median Receivables Turnover is 5.53. Osteopore's value of 1.16 is 79% below this industry median. Based on the distribution chart, Osteopore ranks #708 out of 812 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Osteopore's Receivables Turnover compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Osteopore ranks #708 out of 812 companies for Receivables Turnover. This places Osteopore in the lower half of its industry. The industry median Receivables Turnover is 5.53. Osteopore's value of 1.16 is 79% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.53, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Osteopore's current Receivables Turnover of 1.16 is 79% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Osteopore and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Osteopore's current Receivables Turnover is 1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Osteopore stock overvalued right now?
Based on GuruFocus' analysis, Osteopore (ASX:OSX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 80% below its estimated fair value. The current Receivables Turnover is 1.16 and 79% below the Medical Devices & Instruments industry median of 5.53. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Osteopore (ASX:OSX), the current Receivables Turnover is 1.16 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Osteopore Business Description

Address 2 Tukang Innovation Grove, No. 09-06 and 07, JTC MedTech Hub, Singapore, SGP, 618305
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. It operate in the high-growth regenerative medicine sector, where adoption continues to rise as healthcare systems increasingly embrace developed tissue-regenerative solutions. Business operating segments are based on the firm's geographical presence in Singapore and Australia.